<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(8)</volume><submitter>Wang LJ</submitter><pubmed_abstract>Intrahepatic cholangiocarcinoma (ICC) constitutes the second-most common primary hepatic malignancy. MicroRNAs (miRNAs) play important roles in the pathogenesis of ICC. However, the clinical significance of miR-21 levels in ICC remains unclear. Here, we investigated the role of miR-21 in ICC and found that its expression was significantly upregulated in serum of ICC patients. Serum miR-21 levels robustly distinguished ICC patients from control subjects. Further experiments showed that inhibition of miR-21 suppressed ICC cell proliferation in vitro and tumor growth in vivo. Specifically, inhibition of miR-21 induced cell cycle arrest and apoptosis. Moreover, PTPN14 and PTEN were identified as direct and functional targets of miR-21. Finally, we showed high expression levels of miR-21 were closely related to adverse clinical features, diminished survival, and poor prognosis in ICC patients. This study revealed functional and mechanistic links between miR-21 and tumor suppressor genes, PTPN14 and PTEN, in the pathogenesis of ICC. MiR-21 not only plays important roles in the regulation of cell proliferation and tumor growth in ICC, but is also a diagnostic and prognostic marker, and a potential therapeutic target for ICC.</pubmed_abstract><journal>Oncotarget</journal><pagination>5932-46</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4467412</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.</pubmed_title><pmcid>PMC4467412</pmcid><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>He CC</pubmed_authors><pubmed_authors>Han SX</pubmed_authors><pubmed_authors>Sui X</pubmed_authors><pubmed_authors>Ma JL</pubmed_authors><pubmed_authors>Zhou CY</pubmed_authors><pubmed_authors>Cai MJ</pubmed_authors><pubmed_authors>Wang LJ</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Zhu Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.</name><description>Intrahepatic cholangiocarcinoma (ICC) constitutes the second-most common primary hepatic malignancy. MicroRNAs (miRNAs) play important roles in the pathogenesis of ICC. However, the clinical significance of miR-21 levels in ICC remains unclear. Here, we investigated the role of miR-21 in ICC and found that its expression was significantly upregulated in serum of ICC patients. Serum miR-21 levels robustly distinguished ICC patients from control subjects. Further experiments showed that inhibition of miR-21 suppressed ICC cell proliferation in vitro and tumor growth in vivo. Specifically, inhibition of miR-21 induced cell cycle arrest and apoptosis. Moreover, PTPN14 and PTEN were identified as direct and functional targets of miR-21. Finally, we showed high expression levels of miR-21 were closely related to adverse clinical features, diminished survival, and poor prognosis in ICC patients. This study revealed functional and mechanistic links between miR-21 and tumor suppressor genes, PTPN14 and PTEN, in the pathogenesis of ICC. MiR-21 not only plays important roles in the regulation of cell proliferation and tumor growth in ICC, but is also a diagnostic and prognostic marker, and a potential therapeutic target for ICC.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Mar</publication><modification>2021-02-21T05:17:53Z</modification><creation>2019-03-27T01:53:27Z</creation></dates><accession>S-EPMC4467412</accession><cross_references><pubmed>25803229</pubmed><doi>10.18632/oncotarget.3465</doi></cross_references></HashMap>